Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...
The planned acquisition of Kartos Therapeutics would hand Ipsen a late-stage asset for myelofibrosis. Elsewhere, Sobi hit a ...
Five years in the making, Autheo is launching its decentralized operating system on Mainnet — after public testnet adoption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results